Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation

S. Mallett,D. Cox,A. Burroughs,K. Rolles

DOI: https://doi.org/10.1016/0140-6736(90)92404-6

IF: 202.731

1990-10-06

The Lancet

Abstract:

What problem does this paper attempt to address?

Difficulties in social cognitive functioning among pediatric patients with muscular dystrophies

Irune García,Oscar Martínez,Juan Francisco López-Paz,Maitane García,Alicia Aurora Rodríguez,Imanol Amayra

DOI: https://doi.org/10.3389/fpsyg.2023.1296532

IF: 3.8

2024-01-04

Frontiers in Psychology

Abstract:Introduction Pediatric muscular dystrophies (MDs) are a heterogeneous group of rare neuromuscular diseases characterized by progressive muscle degeneration. A neuropsychosocial approach is crucial for these patients due to associated cognitive, behavioral, and psychiatric comorbidities; however, the social cognitive domain has not been adequately addressed. Methods This study aimed to analyze on social cognition performance in a pediatric MD patient cohort. This cross-sectional study included 32 pediatric patients with MD and 32 matched-healthy controls. The Social Perception Domain of the NEPSY-II, the Reading the Mind in the Eyes Test–Child and Happé’s Strange Stories Test were administered. General intelligence and behavioral and emotional symptoms were controlled for to eliminate covariables’ possible influence. The assessments were performed remotely. Results Children with MDs performed significantly worse on most of the social cognition tasks. The differences found between the groups could be explained by the level of general intelligence for some aspects more related to theory of mind (ToM) (TM NEPSY-II: F = 1.703, p = .197; Verbal task: F = 2.411, p = .125; RMET-C: F = 2.899, p = .094), but not for emotion recognition. Furthermore, these differences were also independent of behavioral and emotional symptoms. Discussion In conclusion, social cognition is apparently impaired in pediatric patients with MD, both for emotion recognition and ToM. Screening assessment in social cognition should be considered to promote early interventions aimed at improving these patient’s quality of life.

psychology, multidisciplinary
Pulmonary and upper limbs function in children with early stage Duchenne muscular dystrophy compared to their healthy peers

Numan Bulut,Güllü Aydın,İpek Alemdaroğlu-Gürbüz,Ayşe Karaduman,Öznur Yılmaz

DOI: https://doi.org/10.1016/j.bjpt.2020.05.012

Abstract:Background: Pulmonary and upper limbs function of children with Duchenne muscular dystrophy (DMD) are known to deteriorate throughout the disease process. However, there is a lack of information on the extent of impairments in the early stages of DMD when compared to healthy peers. Objective: To investigate to what extent pulmonary and upper limbs function of children with early stage DMD are impaired. Methods: Sixty-one children participated in the study: 31 with Grade 1 DMD (study group) according to the Brooke Upper and Lower Extremity Functional Classification Systems, and 30 age matched healthy peers (control group). Pulmonary function was determined with pulmonary function tests. The Performance of Upper Limb test was used to evaluate the upper limbs function. Results: Study and control groups were homogenous in terms of physical characteristics (p>0.05). Pulmonary and upper limbs function of children with DMD were about 85% and 93% of healthy peers, respectively. Conclusion: This study provides evidence for deterioration of pulmonary and upper limbs function in children with early stage DMD. Better knowledge of deterioration rate over time may help therapists to better plan and update their plan of care.
Early motor, cognitive, language, behavioural and social emotional development in infants and young boys with Duchenne Muscular Dystrophy- A systematic review

Jasmine Hoskens,Silke Paulussen,Nathalie Goemans,Hilde Feys,Liesbeth De Waele,Katrijn Klingels

DOI: https://doi.org/10.1016/j.ejpn.2024.07.003

Abstract:Duchenne Muscular Dystrophy (DMD) is an X-linked recessive disorder caused by mutations in the dystrophin gene. Deficiency of the dystrophin protein causes not only motor, but also cognitive, language, behavioural and social emotional problems. This is the first systematic review investigating five early developmental domains in boys with DMD between 0 and 6 years old. Interactions between different domains and links with mutation types and sites were explored. A systematic search was performed in PubMed, Web of Science and Scopus. An adapted version of the Scottish Intercollegiate Guidelines Network (SIGN) Checklists for case-control and cohort studies was used to evaluate quality. Fifty-five studies of high or acceptable quality were included. One was an RCT of level 1b; 50 were cohort studies of level 2b; and four were an aggregation of case-control and cohort studies receiving levels 2b and 3b. We found that young boys with DMD experienced problems in all five developmental domains, with significant interactions between these. Several studies also showed relationships between mutation sites and outcomes. We conclude that DMD is not only characterised by motor problems but by a more global developmental delay with a large variability between boys. Our results emphasise the need for harmonisation in evaluation and follow-up of young boys with DMD. More high-quality research is needed on the different early developmental domains in young DMD to facilitate early detection of difficulties and identification of associated early intervention strategies.
Clinical study on cognitive impairment in Duchenne muscular dystrophy

Xiao-fang Zhang,Yuan-yuan Luo,Li Jiang,Si-qi Hong

DOI: https://doi.org/10.1016/j.nmd.2023.06.001

IF: 3.538

2023-06-18

Neuromuscular Disorders

Abstract:Our study aimed to explore the intellectual function of patients with Duchenne muscular dystrophy (DMD) in China and examine the correlation of full-scale intelligence quotient (FSIQ) with age, mutation locations, mutation class, and dystrophin isoforms. We assessed 64 boys with DMD using The Wechsler Intelligence Scales for Children-Fourth Edition and compared intellectual function at enrollment and follow-up in the 15 patients who completed the follow-up. Our findings confirm that boys with DMD may exhibit cognitive impairment, with the Working Memory Index being the most impaired. There was no significant correlation between FSIQ and age; however, a positive correlation was noted between age and the Verbal Comprehension Index. FSIQ was not associated with mutation class, the number of affected mutated exons, or mutation locations. However, there was a significant difference in FSIQ between the groups with intact and deficient Dp140. Fifteen participants adhered to glucocorticoid therapy throughout the two-year follow-up period, and eleven of them showed an improvement in FSIQ compared to their initial scores, with improvement ranging from 2 to 20. In conclusion, patients with the cumulative loss of isoforms in the brain are at a higher risk of cognitive deficits and may require early cognitive interventions.

neurosciences,clinical neurology
Evolution of neuropsychological and behavioral profile in a cohort of Becker muscular dystrophy pediatric patients in a longitudinal study

Francesca Cumbo,Michele Tosi,Michela Catteruccia,Daria Diodato,Francesco Nicita,Irene Mizzoni,Giacomo De Luca,Adelina Carlesi,Paolo Alfieri,Stefano Vicari,Enrico Silvio Bertini,Adele D'Amico

DOI: https://doi.org/10.1016/j.nmd.2024.01.006

IF: 3.538

2024-01-27

Neuromuscular Disorders

Abstract:It has long been reported that neuropsychological deficits may be present in dystrophinopathies, specifically non-progressive cognitive impairment and a global deficit in executive functions; this neurocognitive profile has been less explored in patients with Becker than Duchenne Muscular Dystrophy (BMD/DMD). We conducted a longitudinal study to explore the evolution of neuropsychological and behavioural profile in a cohort of paediatric BMD. Seventeen patients with BMD without intellectual disability were assessed using a full battery of tests, including intellectual, adaptive and executive functioning, language and behavioral features. Tests were performed at baseline and after 12 months. The results showed adequate cognitive and adaptive profile with falls in Working Memory, as well as lower scores in executive functions. An improvement was observed in Processing Speed. Behavioral questionnaires confirmed a negative trend, while in normal ranges. We found a statistically significant difference between T0 and T1 in some items exploring executive functions. No statistically significant difference was observed stratifying patients by mutation site or IQ level. In conclusion, our study suggests that BMD patients have a stable neurocognitive profile, while a deflection in the executive functions may be observed. We recommend a careful monitoring to intercept learning disabilities and promptly start a multimodal rehabilitation.

neurosciences,clinical neurology
Clinical Features in Boys with Duchenne/Becker Muscular Dystrophy: A Tertiary Center Experience

Muhittin Bodur,Rabia Tutuncu Toker

DOI: https://doi.org/10.5812/ijp-143338

2024-08-27

Iranian Journal of Pediatrics

Abstract:Background: Dystrophin-related muscular dystrophies are a group of diseases caused by mutations in the dystrophin gene that are inherited in an X-linked recessive manner. Objectives: We aimed to discuss the clinical, laboratory, genetic, treatment, and prognostic features, as well as diagnostic clues, of our DMD/BMD patients. Methods: The medical records of 39 children who were followed up with DMD/BMD diagnoses at Bursa Uludağ University Faculty of Medicine Child Neurology Clinic between August 2018 and September 2023 were evaluated retrospectively. DMD or BMD is diagnosed by genetic testing or muscle biopsy. Results: All patients were male, and the age of symptom onset was 3.44 ± 2.7 years (range: 1 - 12.2 years). Twenty-two cases were symptomatic, presenting with difficulty walking (N = 17), difficulty climbing stairs (N = 14), and getting tired quickly (N = 11). Seventeen cases were initially asymptomatic, identified through elevated CK, AST, and ALT levels. Conclusions: Early recognition that increased serum transaminase and CK levels reflect muscle disease accelerates the diagnosis of underlying conditions and protects patients from unnecessary, invasive, and costly diagnostic testing.

pediatrics
Comparison of hand dexterity and hand laterality task in duchenne muscular dystrophy patients with typically developing peers

Demet Gözaçan Karabulut,Çağtay Maden,Sedat Yiğit

DOI: https://doi.org/10.3233/nre-240125

2024-09-02

Neurorehabilitation

Abstract:BACKGROUND: Hand dexterity is important with Duchenne muscular dystrophy (DMD). OBJECTIVE: The aim of this study was to compare hand dexterity and hand laterality task assessments in patients with DMD with typically-developing peers. METHODS: The study included 25 DMD with a mean age of 10.2±2.38 and 21 typically-developing peers with a mean age of 10.33±2.26. Functional levels of DMD patients were determined by Brooke Upper Extremity Functional Classification Scale and Brooke Lower Extremity Functional Scale. The ABILHAND-Kids and 9-hole peg test were used to assess the hand dexterity of all participants, and assess the hand laterality task. RESULTS: Patients with DMD had lower ABILHAND-Kids scores than their typically-developing peers (p < 0.001). Patients with DMD had higher 9-hole peg test duration on the dominant and non-dominant extremity compared to typically-developing peers (p < 0.001). Patients with DMD were found to be different from their typically-developing peers (p < 0.001) in lateralization response time and accuracy. CONCLUSION: Patients with DMD were found to have lower manual dexterity and hand laterality task skills compared to their typically-developing peers. It is recommended that hand dexterity and upper extremity recognition capacities should be considered in assessment and intervention programs for physiotherapists and clinicians working in this field.

clinical neurology,rehabilitation
Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828)

Yuanchao Xie,Weiguo Song,W. Xiao,Changjuan Gu,Wenfang Xu

DOI: https://doi.org/10.1517/13543776.2013.831073

2013-10-17

Expert Opinion on Therapeutic Patents

Abstract:A series of compounds incorporating two aromatic heterocycles were prepared as inhibitors of influenza virus replication in the patent. Some of them presented potent activity against influenza virus in Madin–Darby canine kidney (MDCK) cells and in influenza therapeutic mouse model. These compounds in the patent were also defined to be pharmaceutically acceptable salts and pharmaceutical compositions that were claimed to be useful for treating influenza. In view of the threat of influenza pandemic, it is necessary to discover new anti-influenza drugs. Although there is a lack of essential biological data and the molecular mechanisms are not clear, these compounds with potent antiviral activity stand for a new type of anti-influenza agents and deserve further studies.
Neurocognitive functioning among children and young people with Duchenne Muscular Dystrophy: A systematic review and meta-analysis

Jayne Gregg,Colin Wilson,David Curran,Donncha Hanna

DOI: https://doi.org/10.1080/13854046.2024.2324500

2024-03-22

The Clinical Neuropsychologist

Abstract:Objective: The neurocognitive aspects of DMD have received less attention than the physiological sequalae. This study conducted a systematic review and meta-analysis of available literature on the neurocognitive profile of children and young people with DMD. Method: Five databases (EMBASE, Medline, PsycInfo, Scopus and Web of Science) and the grey literature was searched on 27 th January 2023. Eligible articles were available in English and reported neurocognitive outcomes. Neurocognitive domains reported in a comparable way across a minimum of three studies were included. The neurocognitive domains of Full-Scale IQ (FSIQ), Verbal IQ (VIQ), Performance IQ (PIQ) and Working memory (WMI) derived from Wechsler scales and receptive vocabulary ability derived from the Peabody Picture Verbal Test (PPVT) were included. A single mean meta-analysis was completed. Results: Relevant data was extracted and presented for 38 eligible studies; 2 of which are from grey literature. Results suggest children with DMD perform around 1SD below non-clinical norms for FSIQ, PIQ, VIQ and WMI. Unlike VIQ, scores derived from the PPVT were within the non-clinical norms. Studies were of moderate – high quality, there was significant heterogeneity and no publication bias. Conclusion: A systematic review of working memory has not previously been completed, it appears that children with DMD perform around 1SD below the mean, like FSIQ, PIQVIQ and WMI. The PPVT is a measure of receptive verbal ability and caution is recommended around the interchangeability of PPVT scores and the wider construct of verbal intelligence.

psychology, clinical,clinical neurology
Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients

Ozkalayci, Hande

DOI: https://doi.org/10.1007/s10048-024-00765-9

2024-06-09

Neurogenetics

Abstract:Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive allelic muscle diseases caused by dystrophin gene mutations. Eight hundred thirty-seven patients admitted between 1997 and 2022 were included in the study. Two hundred twenty patients were analyzed by multiplex PCR (mPCR) alone. Five hundred ninety-five patients were investigated by multiplex ligation-dependent probe amplification (MLPA), and 54 patients were examined by sequencing. Deletion was detected in 60% (132/220) of the cases in the mPCR group only and in 58.3% (347/595) of the cases with MLPA analysis. The rates of deletion and duplication were 87.7% and 12.3%, respectively, in the MLPA analysis. Single exon deletions were the most common mutation type. The introns 43–55 (81.8%) and exons 2–21 (13.1%) regions were detected as hot spots in deletions. It was determined that 89% of the mutations were suitable for exon skipping therapy. The reading frame rule did not hold in 7.6% of D/BMD cases (17/224). We detected twenty-five pathogenic/likely pathogenic variants in sequencing, five of which were novel variants. Nonsense mutation was the most common small mutation (44%). 21% of DMD patients were familial. We detected germline mosaicism in four families (4.3%) in the large rearrangement group and one gonosomal mosaicism in a family with a nonsense mutation. This is the largest study examining genotype and phenotype data in Turkish D/BMD families investigated by MLPA analysis. The reading frame hypothesis is not valid in all cases. Sharing the genotype and phenotype characteristics of these cases in the literature will shed light on the molecular structure of DMD and guide gene therapy research. In genetic counseling, carrier screening in the family and possible gonadal mosaicism should be emphasized.

genetics & heredity,clinical neurology
Base-catalysed rearrangement of thebainehydroquinones.

Z. Barneis,J. Carr,R. Warnet,D. Wheeler

DOI: https://doi.org/10.1016/S0040-4020(01)88415-5

IF: 2.388

Tetrahedron

Abstract:
Adaptive fuzzy decentralized control for stochastic large-scale nonlinear systems with unknown dead-zone and unmodeled dynamics

Shaocheng Tong,Shuai Sui,Yong-ming Li

DOI: https://doi.org/10.1016/j.neucom.2013.12.016

IF: 6

2014-07-05

Neurocomputing

Abstract:
The relationship between lower urinary system symptoms and the level of independence and quality of life in children with Duchenne muscular dystrophy

Demet Öztürk,Aynur Ayşe Karaduman,Türkan Akbayrak

DOI: https://doi.org/10.1007/s00467-024-06419-0

Abstract:Background: The purpose was to investigate the frequency of lower urinary tract symptoms (LUTS) and lower urinary tract dysfunction (LUTD) in Duchenne muscular dystrophy (DMD) and the relationship between these symptoms and independence and quality of life (QoL). Methods: The cross-sectional study included children aged 5-18 years and diagnosed with DMD and their families. Data were collected using the Dysfunctional Voiding and Incontinence Scoring System (DVISS), the Barthel Index, and the Pediatric Quality of Life™ 3.0 Neuromuscular Module (PedsQL-NMM). Results: The study was completed with 45 children with DMD. LUTS was found in 86.66% and LUTD was found in 44.44%. The most common symptom was holding maneuvers (62.22%). Other common symptoms were urinary urgency (55.55%), daytime urinary incontinence (46.66%), and enuresis (31.11%). There was a significant correlation of the DVISS with the level of independence and QoL (p < 0.05). Moreover, higher LUTS score was associated with lower Barthel and PedsQL-NMM scores. Conclusion: LUTS is a neglected condition, although it is frequently seen in children with DMD. Clinical trial registration: NCT05464446.
Wernicke's Encephalopathy: A Clinical and Pathological Study of 28 Autopsied Cases

H. Cravioto,J. Korein,J. Silberman

DOI: https://doi.org/10.1001/ARCHNEUR.1961.00450110040005

1961-05-01

Abstract:Introduction "Wernicke's encephalopathy" is the term applied to a disease process characterized pathologically by symmetrical lesions in the mammillary bodies, the walls of the third ventricle, the periaqueductal areas, and the floor of the fourth ventricle. Clinically, the disease is said to be characterized by disturbances of consciousness, paralysis of the external ocular muscles, ataxia, and sometimes polyneuritis. 1,2 The disease results from a thiamine deficiency due to inadequate intake, faulty absorption due to gas trointestinal disturbances, or to unusually increased requirements such as in fever. 3-8 Lesions resembling Wernicke's encephalopathy have been observed as a familial disease in infants in the absence of the above-mentioned circumstances, probably because of a defect in the metabolic pathways in which thiamine is usually involved. 9 Due to the modern diet, often supplemented with vitamins, the avitaminoses have become relatively rare. Individuals addicted to alcohol, however, form a group in which the lack
327P Correlation of biomarkers and timed function tests in pediatric Becker muscular dystrophy

P. Vilaisaktipakorn,A. Zygmunt,T. Sharaf,Y. Shiuan,P. Horn,J. Bange,L. Reebals,I. Rybalsky,C. Tian

DOI: https://doi.org/10.1016/j.nmd.2024.07.667

IF: 3.538

2024-10-04

Neuromuscular Disorders

Abstract:The dystrophinopathies are X-linked progressive muscular dystrophies caused by pathogenic variants in DMD gene resulting in reduced or absent function of dystrophin. Becker muscular dystrophy (BMD) has a milder and more heterogenous course than the more commonly studied Duchenne muscular dystrophy (DMD). There is no disease-modifying treatment for BMD to date. There are ongoing clinical trials for potential therapies for individuals with BMD. Trackable biomarkers could improve disease progression monitoring and drug effect detection. Previous studies reported association of biomarkers in DMD and motor function progression. Limited data was reported on biomarkers in BMD, with none involving the pediatric population. Our aim in this study was to assess changes in selected biomarkers in BMD in relationship to motor function progression in a pediatric cohort. We retrospectively studied 86 patients with BMD with 455 encounters that occurred from July 1, 2008 to April 1, 2022. The mean age of patients at diagnosis is 6.7 years. We extracted biomarker data of serum creatine kinase (CK), serum creatinine (Cr), urine Cr, and urine Cr/urine osmolality (osm), appendicular lean body mass index (ALMI), as well as timed motor function tests, including the 10-Meter Walk/Run Velocity (10MWRV) and the 4 Stair Ascent Velocity (4SAV). Data were analyzed using linear mixed-models with repeated measures. Results showed motor function declined with decreasing CK, serum Cr, urine Cr, and urine Cr/urine osm ratio and ALMI, demonstrated by decreased 10MWRV (p-values of 0.019, 0.003, and 0.028, respectively). The 4SAV decreased with decreasing serum Cr (p-value 0.038). Our study has demonstrated that these biomarkers may complement functional measures in the assessment of individuals with BMD. Future studies can elucidate the predictive utility of these biomarkers in assessing the progression of motor function in BMD.

neurosciences,clinical neurology
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study

Garazi Labayru,Jone Aliri,Miren Zulaica,Adolfo López de Munain,Andone Sistiaga

DOI: https://doi.org/10.1111/jnp.12192

Abstract:Background: Myotonic dystrophy type 1 (DM1) is an inherited multi-systemic disease involving the central nervous system (CNS) and is consequently characterized by a range of cognitive impairments. However, whether this cognitive profile progresses over time is still a matter of debate. The aim of this study was to longitudinally assess a DM1 sample, in order to compare, for the first time, this progression with that of a control group. Clinical and socio-demographic predictive factors potentially implicated in this possible decline are analysed. Method: Seventy-five DM1 patients with childhood, juvenile, adult, and late-onset, and 54 control participants were re-assessed in an 11-year follow-up with a comprehensive neuropsychological battery. The analyses employed were mixed ANOVA for repeated measures to test intergroup comparisons over time and multiple linear regression for predictive variable analysis. Results: Myotonic dystrophy type 1 patients significantly worsened in visuospatial/visuoconstructive abilities and visual memory compared with controls. Multiple linear regression revealed that progression of cognitive impairment measured by copy of the Rey-Osterrieth complex figure was predicted by muscular impairment, whilst on the block design test age predicted the change with a cut-off at 31 years of age. Discussion: A domain-specific progressive cognitive decline was found in DM1, with visuospatial/visuoconstructive abilities showing the greatest vulnerability to the passage of time. In addition to important clinical implications, these results suggest the need for the scientific community to delve deeper into the potential mechanisms underlying early cognitive decline in this population.
Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71

Rubén Miranda,Léa Ceschi,Delphine Le Verger,Flora Nagapin,Jean-Marc Edeline,Rémi Chaussenot,Cyrille Vaillend

DOI: https://doi.org/10.1186/s12993-024-00246-x

IF: 5.1

2024-08-27

Behavioral and Brain Functions

Abstract:The Duchenne and Becker muscular dystrophies (DMD, BMD) are neuromuscular disorders commonly associated with diverse cognitive and behavioral comorbidities. Genotype–phenotype studies suggest that severity and risk of central defects in DMD patients increase with cumulative loss of different dystrophins produced in CNS from independent promoters of the DMD gene. Mutations affecting all dystrophins are nevertheless rare and therefore the clinical evidence on the contribution of the shortest Dp71 isoform to cognitive and behavioral dysfunctions is limited. In this study, we evaluated social, emotional and locomotor functions, and fear-related learning in the Dp71-null mouse model specifically lacking this short dystrophin.

behavioral sciences,neurosciences
Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up

Isabelle Desguerre,Christo Christov,Michele Mayer,Reinhard Zeller,Henri-Marc Becane,Sylvie Bastuji-Garin,France Leturcq,Catherine Chiron,Jamel Chelly,Romain K. Gherardi

DOI: https://doi.org/10.1371/journal.pone.0004347

IF: 3.7

2009-02-05

PLoS ONE

Abstract:BACKGROUND: To explore clinical heterogeneity of Duchenne muscular dystrophy (DMD), viewed as a major obstacle to the interpretation of therapeutic trialsMETHODOLOGY/PRINCIPAL FINDINGS: A retrospective single institution long-term follow-up study was carried out in DMD patients with both complete lack of muscle dystrophin and genotyping. An exploratory series (series 1) was used to assess phenotypic heterogeneity and to identify early criteria predicting future outcome; it included 75 consecutive steroid-free patients, longitudinally evaluated for motor, respiratory, cardiac and cognitive functions (median follow-up: 10.5 yrs). A validation series (series 2) was used to test robustness of the selected predictive criteria; it included 34 more routinely evaluated patients (age>12 yrs). Multivariate analysis of series 1 classified 70/75 patients into 4 clusters with distinctive intellectual and motor outcomes: A (early infantile DMD, 20%): severe intellectual and motor outcomes; B (classical DMD, 28%): intermediate intellectual and poor motor outcome; C (moderate pure motor DMD, 22%): normal intelligence and delayed motor impairment; and D (severe pure motor DMD, 30%): normal intelligence and poor motor outcome. Group A patients had the most severe respiratory and cardiac involvement. Frequency of mutations upstream to exon 30 increased from group A to D, but genotype/phenotype correlations were restricted to cognition (IQ>71: OR 7.7, 95%CI 1.6-20.4, p<0.003). Diagnostic accuracy tests showed that combination of "clinical onset <2 yrs" with "mental retardation" reliably assigned patients to group A (sensitivity 0.93, specificity 0.98). Combination of "lower limb MMT score>6 at 8 yrs" with "normal or borderline mental status" reliably assigned patients to group C (sensitivity: 1, specificity: 0.94). These criteria were also predictive of "early infantile DMD" and "moderate pure motor DMD" in series 2.CONCLUSIONS/SIGNIFICANCE: DMD can be divided into 4 sub-phenotypes differing by severity of muscle and brain dysfunction. Simple early criteria can be used to include patients with similar outcomes in future therapeutic trials.

multidisciplinary sciences
Computerized working memory training in males with Duchenne muscular dystrophy: A single case experimental design study

Sylvia Klinkenberg,Danique M. J. Hellebrekers,Jose M.A. Wirken,Judith M. Lionarons,Sander M.J. van Kuijk,Johan S.H. Vles,Jos G.M. Hendriksen

DOI: https://doi.org/10.1080/09602011.2022.2096080

2022-07-24

Neuropsychological Rehabilitation

Abstract:Learning disabilities (LDs) and working memory problems (WM) are common brain-related comorbidities in Duchenne muscular dystrophy (DMD). Despite growing evidence on the efficacy of computerized WM training in children with LDs, research in DMD is lacking. This exploratory study assessed whether training (1) improves dystrophin-associated WM problems in DMD, (2) effects are present at post-intervention, 3 and 8 months follow-up, and (3) improves problems that arise from their LDs. A single case non-concurrent multiple baseline across patients design evaluated the target behaviour i.e. parental reports of WM problems of four DMD participants with LDs. Additionally, participants completed cognitive tests of verbal and visual WM, academics, attention, processing speed and fluid reasoning. Parents and teachers completed behavioural questionnaires. Testing and questionnaires were administered at baseline, post-intervention (T2), 3 (T3) and 8 (T4) months follow-up. Positive effects on target behaviour were found for three of four participants, but parental bias cannot be ruled out. Short and long-term, near-and far transfer effects were found for verbal and visual WM (T2: n = 2, T3&T4: n = 1), reading (T2: n = 4,T3: n = 3,T4: n = 2), arithmetic (all T: n = 1), processing speed (all T: n = 4) and fluid reasoning (T2: n = 1,T3&T4: n = 2). Behavioural questionnaires displayed minimal changes (T2: n = 1,T3&T4: n = 2). Promising WM training results are shown in DMD that merit further research.

psychology,neurosciences
Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1

E. K. Erokhina,K. V. Shamtieva,E. A. Melnik,D. O. Kazakov,S. A. Kurbatov,E. P. Pavlikova,O. A. Tikhonova,E. A. Mershina,V. E. Sinitsyn,D. V. Vlodavets

DOI: https://doi.org/10.17650/2222-8721-2024-14-2-12-24

2024-05-24

Neuromuscular Diseases

Abstract:Background. Myotonic dystrophy type 1 (DM1) is a hereditary slowly progressive multisystem disease with an autosomal dominant mode of inheritance, caused by the expansion of trinucleotide (CTG) n repeats in the 3’ untranslated region of the DMPK gene. Among the clinical manifestations of DM1, an important place is occupied by symptoms of damage to the central nervous system, in particular cognitive and emotional disorders. Aim. To evaluate the type of cognitive and emotional impairments in patients with different forms of DM1 and their impact on quality of life. Materials and methods. 60 patients with genetically confirmed DM1 were examined (average age 37.0 ± 12.4 years; 36 (60.0 %) of them were men). All patients underwent neuropsychological testing using the Montreal Cognitive Rating Scale, Mini‐Mental State Examination, Addenbrooke’s III, Wechsler tests, pathfinding, symbolic and numeric modalities, Luria’s 10 Words, Frontal Dysfunction Battery; assessment of emotional disturbances using the Hospital Anxiety and Depression Rating Scale and the Apathy Scale; quality of life assessment – 36‐Item Short‐Form Medical Outcomes Study. Brain magnetic resonance imaging was performed in 53 patients to assess the severity of white matter lesions and gray matter atrophy. Results. The study included 8 (13.3 %) patients with congenital, 19 (31.7 %) – childhood, 33 (55 %) – adult forms of MD1. The group of patients with the congenital form had the most severe cognitive deficits, especially in tests of executive functions and visuospatial perception. Cognitive impairment was also characteristic of the adult form, but to a lesser extent. Compared to controls, patients with DM1 were significantly more likely to exhibit apathy ( p = 0.002) rather than anxiety and depression. In DM1, damage to both the white and gray matter of the brain was established, and a connection between damage to the gray matter and depression (r = 0.296) and apathy (r = –0.291) was revealed. The quality of life is largely influenced by emotional disorders (anxiety, r = –0.577; depression, r = –0.650; apathy, r = –0.545). Conclusion. In patients with DM1, a typical pattern of cognitive impairment has not been identified; different domains of cognitive functions are affected. The greatest cognitive deficit is typical for the group of patients with the congenital form. A connection between damage to the gray matter of the brain and emotional disorders has been revealed. The presence of the latter reduces the quality of life of patients with DM1.

Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation

Difficulties in social cognitive functioning among pediatric patients with muscular dystrophies

Pulmonary and upper limbs function in children with early stage Duchenne muscular dystrophy compared to their healthy peers

Early motor, cognitive, language, behavioural and social emotional development in infants and young boys with Duchenne Muscular Dystrophy- A systematic review

Clinical study on cognitive impairment in Duchenne muscular dystrophy

Evolution of neuropsychological and behavioral profile in a cohort of Becker muscular dystrophy pediatric patients in a longitudinal study

Clinical Features in Boys with Duchenne/Becker Muscular Dystrophy: A Tertiary Center Experience

Comparison of hand dexterity and hand laterality task in duchenne muscular dystrophy patients with typically developing peers

Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828)

Neurocognitive functioning among children and young people with Duchenne Muscular Dystrophy: A systematic review and meta-analysis

Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients

Base-catalysed rearrangement of thebainehydroquinones.

Adaptive fuzzy decentralized control for stochastic large-scale nonlinear systems with unknown dead-zone and unmodeled dynamics

The relationship between lower urinary system symptoms and the level of independence and quality of life in children with Duchenne muscular dystrophy

Wernicke's Encephalopathy: A Clinical and Pathological Study of 28 Autopsied Cases

327P Correlation of biomarkers and timed function tests in pediatric Becker muscular dystrophy

Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study

Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71

Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up

Computerized working memory training in males with Duchenne muscular dystrophy: A single case experimental design study

Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1